Lv625
2618 积分 2024-09-24 加入
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
29天前
已完结
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
29天前
已完结
The broken cycle: E2F dysfunction in cancer
29天前
已完结
Cell-Cycle Therapeutics Come of Age
29天前
已完结
Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs
1个月前
已完结
New 4-Benzenesulfonamide Derivatives of Pyrazolo[1,5-a] [1, 3, 5]triazine as Purine Bioisosteres: Development, Synthesis, and Anticancer Perspective
1个月前
已完结
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitorsfor Treating Cancer
1个月前
已完结
Myrtleciclib, a CDK4/6/9 Inhibitor for the Treatment of AggressiveCancers
1个月前
已完结
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
1个月前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
1个月前
已完结
皖公网安备34019202002308
